Evolus and IBSA Partner on Skin Quality Filler for US Market
Evolus and IBSA will develop and commercialize a skin quality filler in the US, pairing IBSA's formulation with Evolus's aesthetics commercial infrastructure.
Topic
Topic
Evolus and IBSA will develop and commercialize a skin quality filler in the US, pairing IBSA's formulation with Evolus's aesthetics commercial infrastructure.
Evolus confirmed plans to bring its Estyme hyaluronic acid injectable filler line to Europe, marking the company's first dermal f…